Dr. Kornblau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1400 Holcombe Blvd
Unit 428
Houston, TX 77030Phone+1 713-792-8760Fax+1 713-794-1938- Is this information wrong?
Education & Training
- Royal Free Hospital,MD, Benign hematology, 1991 - 1991
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
- Baylor College of MedicineResidency, Internal Medicine, 1985 - 1988
- University of Texas Medical Branch School of MedicineClass of 1985
Certifications & Licensure
- FL State Medical License 2021 - Present
- GA State Medical License 2023 - 2026
- WA State Medical License 2023 - 2026
- TX State Medical License 1986 - 2025
- TN State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- OK State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- Join now to see all
Publications & Presentations
PubMed
- Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study.Bazinet, A., Garcia-Manero, G., Short, N., Alvarado, Y., Bataller, A., Abuasab, T., Islam, R., Montalbano, K., Issa, G., Maiti, A., Yilmaz, M., Jain, N., Masarova, L.,...> ;The Lancet. Haematology. 2024 Mar 4
- Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators.Kelly R Barnett, Robert J Mobley, Jonathan D Diedrich, Brennan P Bergeron, Kashi Raj Bhattarai, Alexander C Monovich, Shilpa Narina, Wenjian Yang, Kristine R Crews, Ch...> ;Cell Genomics. 2023 Dec 13
- Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells.Lauren Rowland, Brandon Smart, Anthony Brown, Gino M Dettorre, Yoshihiro Gocho, Jeremy Hunt, Wenjian Yang, Satoshi Yoshimura, Noemi Reyes, Guoqing Du, August John, Dyl...> ;Bio-Protocol. 2023 Aug 5
- Join now to see all
Journal Articles
- Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia Delineates Lineage Associated Molecular SubtypesKoichi Takahashi, Marina Konopleva, Steven Kornblau, Hagop Kantarjian, Nitin Jain, Elias Jabbour, Courtney D DiNardo, Michael Andreeff, Nature
- Integrative Genomic Analysis of Adult Mixed Phenotype Acute Leukemia Delineates Lineage Associated Molecular SubtypesKoichi Takahashi, Nitin Jain, Courtney D. DiNardo, Steven Kornblau, Carlos Bueso-Ramos, Marina Konopleva, Hagop Kantarjian, Nature
- Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic LeukaemiaMichael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature
Abstracts/Posters
- Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax RegimensSteven M. Kornblau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Ultra-Accurate Assessment of Pretreatment ABL1 Kinase Domain (KD) Mutations in Patients (pts) with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic...Steven M. Kornblau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Mitochondrial Protease, Neurolysin (NLN), Regulates Respiratory Chain Complex and Supercomplex Formation and Is Necessary for AML ViabilitySteven M. Kornblau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Mechanisms Underlying Superior Efficacy of Co-Targeting BET Proteins and Anti-Apoptotic BCL2 or MCL1 Protein Against AML Blast Progenitor Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Novel BET Protein Degrader-Based Combinations Exert Lethality Against Human AML Resistant to BET Inhibitors Due to Increased Activity of β-Catenin-TCF7L2- MYC Axis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromoso...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- A Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (Pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)October 2017
Press Mentions
- Myelodysplastic Syndrome Survivor: A Stem Cell Transplant Put Me in RemissionSeptember 3rd, 2019
- New TMC Program Will Streamline Clinical TrialsJune 3rd, 2019
Grant Support
- Core B - Myeloma Tissue CoreNational Cancer Institute2010–2011
- CML Cell BankNational Cancer Institute2010–2011
- Pathology And Tissue CoreNational Cancer Institute2008–2011
- Sample Distribution, Processing And Culture CoreNational Cancer Institute2007–2011
- High Throughput Transcriptomics And ProteomicsNational Cancer Institute2007–2011
- Sample Distribution, Processing, Banking And DatabaseNational Cancer Institute2005–2009
- Core--Sample Distribution, Processing And CultureNational Cancer Institute2001–2002
- Suicidal Lymphocytes For Induction Of Gvl--CmlNational Cancer Institute1998–2002
- Core--Cell Collection, Fractionation, Growth, And Transplantation LaboratoryNational Cancer Institute1996–2001
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: